Is Achyut Healthcare a good stock to invest in?

Achyut Healthcare is trading -4.87% lower at Rs 5.67 as compared to its last closing price. Achyut Healthcare has been trading in the price range of 6.25 & 5.67. Achyut Healthcare has given 43.86% in this year & 8.72% in the last 5 days.

The company posted a net profit of 0.35 Crores in its last quarter.

Listed peers of Achyut Healthcare include Everest Organics (9.10%), Lasa Supergenerics (-1.11%), Achyut Healthcare (-4.87%) etc.

Achyut Healthcare has a 53.89% public holding. The FII holding in Achyut Healthcare was at 6.14% in 30 Sep 2024. The FII holding has - from the last quarter.

5.67 -0.29 (-4.87%)Updated : Wed 11 Dec, 2024 | 14:25:30

Achyut Healthcare share price range

Today's Low

5.67

Today's High

6.25

52 Week Low

2.87

52 Week High

6.17

Achyut Healthcare share Key Metrics

Updated on 11 Dec 2024, 01:10 AM IST

Market Cap ( ₹ Cr.)

140.39

Beta	-
Div. Yield (%)	0.00
P/B	0.33
D/E	-
Open Price	6.25

TTM P/E	-
Peg. Ratio	0.08
Sector P/E	29.02
Prev. Close	5.96

View All Metrics

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available

Bearish
Moderately Bearish
Neutral
Moderately Bullish
Bullish

Insight: Trends unavailable at the moment.

Achyut Healthcare Financials

INCOME
BALANCE SHEET
Cashflow

Annual

Quarterly

Period	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Total Revenue	6.14	2.70	4.05	0.27
Selling/ General/ Admin Expenses Total	0.11	0.07	0.03	-
Depreciation/ Amortization	0.01	0.01	0.01	-
Other Operating Expenses Total	0.47	0.94	0.74	0.03
Total Operating Expense	6.12	2.98	4.09	0.26
Operating Income	0.02	-0.28	-0.04	0.01
Net Income Before Taxes	0.74	0.31	0.10	0.01
Net Income	0.57	0.23	0.04	0.01
Diluted Normalized EPS	0.34	0.16	0.04	0.01

*All figures in crores except per share values

View detailed financials

Achyut Healthcare forecast

Income Sheet (In Cr)Net Income Vs Revenue

Returns Metrics (In Cr)ROA Vs ROE

Mutual Fund Ownership

Ownership as on: Wed, 11 Dec, 2024

PGIM India Small Cap Fund Regular Growth

1/5

Equity

Amount Invested (Cr.)24.85

% of AUM1.70%

Union Focused Fund Regular Growth

3/5

Equity

Amount Invested (Cr.)6.52

% of AUM1.62%

Navi ELSS Tax Saver Fund Regular Growth

1/5

Equity

Amount Invested (Cr.)0.92

% of AUM1.49%

Union Value Fund Regular Growth

3/5

Equity

Amount Invested (Cr.)3.38

% of AUM1.42%

HSBC Equity Savings Growth

4/5

Hybrid

Amount Invested (Cr.)3.63

% of AUM1.32%

View All

Achyut Healthcare Corporate actions

Board Meetings
AGM
Dividends
Bonus
Split
Rights

Meeting Date	Purpose
19-Oct-24	Half Yearly Results, Bonus & Stock Split
28-May-24	Audited Results
15-Nov-23	Preferential issue of shares
04-Nov-23	Half Yearly Results
27-May-23	Audited Results
05-Jan-23	Preferential issue of shares
21-Nov-22	Preferential issue of shares
12-Nov-22	Half Yearly Results
26-May-22	Audited Results

Meeting Date	Announcement On	Purpose
19-Nov-24	23-Oct-24	EGM
30-Sep-24	10-Sep-24	AGM
15-Dec-23	23-Nov-23	EGM
23-Sep-23	28-Aug-23	AGM
17-Apr-23	21-Mar-23	EGM

Announcement Date	Record Date	Ex-Bonus	Description
19-Oct-24	10-Dec-24	10-Dec-24	Bonus issue in the ratio of 4:10 of Re. 1/-.
18-Mar-23	25-Apr-23	25-Apr-23	Bonus issue in the ratio of 1:2 of Rs. 10/-.

Ex-Splits	Old FV	New FV	Description
10-Dec-24	10	1	Stock split from Rs. 10/- to Re. 1/-.

View All

Achyut Healthcare Company profile

ABOUT Achyut Healthcare

Industry Biotechnology & Drugs
ISIN INE0K1401020
BSE Code 543499
NSE Code -

Achyut Healthcare Limited is an India-based pharmaceutical trading company. The Company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company is engaged in the business of pharmaceutical formulations in the forms of tablets, capsules, oral liquid and injectable. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Achyut Healthcare Management

Jigen Modi Chief Financial Officer, Managing Director, Executive Director
Drashti Unadkat Company Secretary & Compliance Officer
Amisha Modi Executive Director

FAQs about Achyut Healthcare share price

Achyut Healthcare is trading at 5.67 as on Wed Dec 11 2024 08:55:30. This is -4.87% lower as compared to its previous closing price of 5.96.

The market capitalization of Achyut Healthcare is 140.39 Cr as on Wed Dec 11 2024 08:55:30.

The 52 wk high for Achyut Healthcare is 6.17 whereas the 52 wk low is 2.87

Achyut Healthcare can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 29.02
Dividend Yield: 0.00%
D/E ratio: -

Achyut Healthcare reported a net profit of 0.57 Cr in 2024.

Trending Stocks

Bajaj Finance share price

7,115.75+180.85(2.61%)

Nestle India share price

2,242.90+27.25(1.23%)

Bajaj Finserv share price

1,684.00+19.95(1.20%)

NTPC share price

365.55-3.25 (-0.88%)

State Bank Of India share price

861.55-6.05 (-0.70%)

Home Markets Premium Instant Loan Mint Shorts

1 Week	8.72%
3 Months	66.88%
6 Month	54.52%
YTD	43.86%
1 Year	56.55%

Achyut Healthcare share price

Achyut Healthcare share price range

Achyut Healthcare share Key Metrics

Achyut Healthcare stock Analysis

Technical Trends

Long Term
Considers price movement over the last 6 months

Short Term
Considers price movement over the last 1-2 weeks

Achyut Healthcare share price news

Amazon limited time deals on air purifiers from Honeywell, Dyson and more, up to 66% off

Amazon best deals on vacuum cleaners and water purifiers: Grab min 50% off on Eureka Forbes and Aquaguard

Eureka Forbes to boost distribution, launch new products amid portfolio overhaul

Stocks to Watch: Wipro, Eureka Forbes, Vedanta, Bank of Baroda, Zee

Eureka Forbes promoter to sell 12% stake for $138.6 million

Achyut Healthcare Financials

Achyut Healthcare forecast

Achyut Healthcare Technical

Achyut Healthcare Shareholding

Shareholding Pattern

PGIM India Small Cap Fund Regular Growth

Union Focused Fund Regular Growth

Navi ELSS Tax Saver Fund Regular Growth

Union Value Fund Regular Growth

HSBC Equity Savings Growth

Achyut Healthcare Corporate actions

Achyut Healthcare Company profile

ABOUT Achyut Healthcare

Achyut Healthcare Management

FAQs about Achyut Healthcare share price

Achyut Healthcare Quick Links

Equity Quick Links

Achyut Healthcare share price

Achyut Healthcare share price range

Achyut Healthcare share Key Metrics

Achyut Healthcare stock Analysis

Long TermConsiders price movement over the last 6 months

Short TermConsiders price movement over the last 1-2 weeks

Achyut Healthcare Financials

Achyut Healthcare forecast

Achyut Healthcare Technical

Achyut Healthcare Shareholding

Shareholding Pattern

Achyut Healthcare Corporate actions

Achyut Healthcare Company profile

ABOUT Achyut Healthcare

Achyut Healthcare Management

FAQs about Achyut Healthcare share price

Achyut Healthcare Quick Links

Equity Quick Links

Wait for it…

Wait for it…

Long Term
Considers price movement over the last 6 months

Short Term
Considers price movement over the last 1-2 weeks